Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
Duygu Has Şimşek, Serkan Kuyumcu, Seyfullah Karadogan, Melis Oflas, Emine Göknur Işık, Zeynep Gözde Özkan, Nail Paksoy, Özgül Ekmekçioğlu, Meltem Ekenel, Yasemin Şanlı
Topics & Concepts
MedicineDocetaxelProstate cancerOncologyInternal medicineProportional hazards modelLogistic regressionMultivariate analysisUrologyUnivariate analysisProstateCancerProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications